Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II Trial.
Cruz-Lim EM, Mou B, Jiang W, Liu M, Bergman A, Schellenberg D, Alexander A, Berrang T, Bang A, Chng N, Matthews Q, Carolan H, Hsu F, Miller S, Atrchian S, Chan E, Ho C, Mohamed I, Lin A, Huang V, Mestrovic A, Hyde D, Lund C, Pai H, Valev B, Lefresne S, Tyldesley S, Olson R, Baker S.
Cruz-Lim EM, et al.
Clin Oncol (R Coll Radiol). 2024 Mar;36(3):141-147. doi: 10.1016/j.clon.2024.01.007. Epub 2024 Jan 17.
Clin Oncol (R Coll Radiol). 2024.
PMID: 38296662
Clinical Trial.